ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

2021 American Transplant Congress

June 4-9, 2021

ATC 2021 Virtual Connect is an all-new, completely enhanced virtual meeting experience. The ATC program is built in Eastern Time Zone.

View by Title View Sessions View Topics
View by Date
Jump to:  View All • a b c d e f g h [i] j k l m n o p q r s t u v w x y z
  • I Would Do Whatever It Took”: Understanding the Motivation, Education and Experiences of Kidney Paired Donation Participants

    R. Pines1, Y. A. Iraheta2, L. Ambriz2, K. A. Dahmani2, E. H. Wood2, M. Cooper3, A. D. Waterman2

  • Iatrogenic Sodium Exposure in Hospitalized Patients with Liver Disease

    P. Klem1, R. Mbangu Kot Mbau2, B. Crowther1, V. Lewis1, S. Lin1, E. Patrick3, A. Nadrash1, K. Schoeppler1, I. Kim1

  • Identification and Comprehensive Validation of Prognostic Genes After Ischemic and Reperfusion Injury Across Different Donor Types in Renal Transplantation

    D. Zhang, Y. Wang, Y. Wang, X. Hu

  • Identification and Validation of a Prognostic Index for Renal Allograft Survival Based on the Geo Database

    X. Zhang, Z. Wang, Z. Han, J. Tao, X. Ju, R. Tan, M. Gu

  • Identification of Distinct Blood Monocyte Phenotypes from Transplant Kidney Recipients Undergoing Cellular (TCMR) and Mixed Antibody Mediated Rejection (ABMR)

    C. Macedo, E. Bailly, K. Louis, M. Lucas, A. Zeevi, P. Randhawa, D. Metes

  • Identification of Molecular Markers for Liver Cirrhosis by Single-nucleus Rna Sequencing

    C. Kuscu1, C. Kuscu1, M. Akram2, A. Shetty3, D. G. Maluf4, J. Eason1, V. Mas5

  • Identifying Barriers to Transition Readiness in Pediatric Kidney Transplant Patients

    K. Amatya, S. Yuhas-Schiltz, C. Petyak, A. Moudgil

  • Identifying Health-System Level Barriers and Facilitators to Living Donor Kidney Transplantation: A Comparative Case Study

    A. Horton1, M. Fortin2, P. Nugus3, D. Landsberg4, M. Paquet2, M. Cantarovich1, S. Sandal1

  • Identifying the Needs of Kidney Transplant Recipients That Can be Addressed by a Web-based Self-management Program

    D. Massierer1, R. Sapir-Pichhadze2, V. Bouchard3, K. Dasgupta2, N. Fernandez4, D. da Costa2, S. Ahmed1, M. Fortin5, R. Langevin6, N. Mayo1, T. Janaudis-Ferreira1

  • IFNγ, and to a Lesser Extent TNFα, Elicits Protracted Endothelial Cell Expression of Costimulatory Molecules and Antigen Presentation Machinery

    N. M. Valenzuela

  • Iguratimod Prevents Antibody-mediated Rejection by Regulating Germinal Center Formation and Antibody Production

    H. Zhang, A. Chandraker, P. Sage, N. Murakami

  • Iguratimod Reduce Panel Reactive Antibody in High Mismatched Renal Transplant Recipients: A Retrospective Propensity Score-Matched Study

    D. Feng, Z. Wang, Z. Han, J. Tao, X. Ju, R. Tan, M. Gu

  • Ikaros-SIRT1 Signaling Axis Regulates Macrophage Polarization and Ischemia Reperfusion Injury in Mouse and Human Liver Transplantation

    K. Kadono1, H. Hirao1, H. Kojima1, K. J. Dery1, X. Li2, J. W. Kupiec-Weglinski1

  • IL-10 Signaling in T Cells Modulates Costimulation-independent Activation and is Essential for Transplant Tolerance Induction

    M. Iglesias Lozano1, D. Bibicheff1, M. Chicco2, A. Komin1, G. Brandacher1, G. Raimondi1

  • Imaging Flow Cytometry Reveals That Platelet-Sized Erythrocyte Fragments are Formed During Pig Organ Perfusion with Human Blood

    Z. A. Habibabady1, F. Ellett2, L. Burdorf1, M. Connolly1, F. Pollok1, D. Irimia2, R. N. Pierson III1, A. M. Azimzadeh1

  • Immune Response to Covid-19 in Kidney Transplant Waitlist Patients

    P. T. Jindra1, C. M. Foye1, I. Sharf2, A. Rana1, T. N. Galvan1, A. Awan1, C. A. O'Mahony1, B. V. Murthy1

  • Immunologic Benefits of Maternal Living Donor Allografts in Pediatric Liver Transplantation: Less Rejection Episodes and No Evidence of De Novo Allosensitization

    A. Barbetta1, G. Meeberg2, B. Rocque1, S. Barhouma3, S. Gilmour4, F. Faytrouni5, O. Guttman5, P. Campbell4, J. Shapiro2, J. Emamaullee1

  • Immunologic Endotypes of Ischemia-reperfusion Injury in Human Liver Transplantation

    R. A. Sosa, A. Q. Terry, F. M. Kaldas, B. V. Naini, T. Ito, R. W. Busuttil, D. W. Gjertson, J. W. Kupiec-Weglinski, E. F. Reed

  • Immunosuppression and Cancer Risk in Kidney Transplant Recipients: A Retrospective Cohort Study

    R. Sapir-Pichhadze1, C. Laprise1, X. Zhang1, M. Abrahamowicz1, M. Beauchamp2, A. Della Vecchia1, L. Azoulay1, E. Franco1, B. Nicolau1

  • Immunosuppression Impacts Panel Reactive Antibody Status in Second Solid Organ Transplant Recipients – A Single Center Experience

    J. Patel1, S. Ali2, M. L. Sanders1, C. P. Thomas1, D. Axelrod1, M. Bilal3, E. H. Field3, S. Kuppachi1

  • Immunosuppression in Uterine Transplant Recipients: Experience from the Largest Uterine Transplant Program

    N. Wilson, R. Patel, L. Johannesson, G. Testa, T. Sam

  • Immunosuppression is Not Associated with High-risk Immunologic Parameters in Transplant Recipients with the Sars-cov2 Virus

    S. Merl, R. Jones, B. Shonts, D. Rust, M. Sykes, J. Weiner

  • Immunosuppression Reduction Strategies for Polyoma BK Viremia in Kidney Transplant Patients on Belatacept-Based Immunosuppression

    O. Roe1, E. Meredith1, A. Reid2, A. Basu3

  • Immunosuppression Regimen and Risk of Posttransplant Diabetes Among Older Kidney Transplant Recipients

    K. Lentine1, J. Ahn2, M. McAdams Demarco2, H. Xiao1, S. Bunnapradist3, D. Segev2, D. Axelrod1, S. Bae2, V. Dharnidharka4, Y. Caliskan1, S. Chang4, G. Hess5, J. Snyder6, M. Schnitzler1

  • Immunotherapy of Dc-cik Cells in Patient with Hepatocellular Carcinoma Recurrence Following Liver Transplantation

    S. Hsu, L. Jeng, H. Yang, A. Thorat

  • Impact Analysis of Virtual Transplant Ambulatory Pharmacist During Covid-19

    L. Park, G. Waldman, J. Kim, C. Rogers, J. Clark

  • Impact of a “COVID-free” Pathway on Living Donor Transplantation During a Pandemic

    S. Koganti, Y. Cheah, C. J. Simon, M. Tobon Lascano, J. Kim, M. E. Akoad

  • Impact of a Cmv Cell Mediated Immunity Based Protocol on Guiding Cmv Prophylaxis Following Pediatric Liver Transplantation – A Single Center Experience

    G. Kalkan1, S. Ball2, L. McConnell2, D. M. Desai3, A. Aqul3, P. K. Sue1

  • Impact of a Latinx Kidney Transplant Clinic

    P. Serrano Rodriguez

  • Impact of a Pharmacist in an Outpatient Heart Transplant Clinic

    A. Prom1, D. Ricciuti1, J. Newman2, C. Doligalski1

  • Impact of a Pharmacist-driven Immunization Clinic on Vaccination Rates in Pre-liver Transplant Patients

    A. Poparad-Stezar1, B. Summers1, M. Fitzmaurice1, K. Hakamiun2, N. Sulejmani3, A. Jantz1

  • Impact of Advanced Renal Dysfunction on Post-Transplant Outcomes After Living Donor Liver Transplantation in the United States

    T. Bittermann1, N. Kaur2, P. L. Abt1, K. M. Olthoff1, J. K. Heimbach3, J. Emamaullee2

  • Impact of Allosensitization on Xenotransplantation

    D. Olaso1, M. Manook1, J. Yoon1, Y. Bae1, A. Barbas1, A. Adams2, S. Knechtle1, J. Kwun1

  • Impact of Bacterial Infection on HLA Allosensitization Among Kidney Recipients on the Waitlist

    D. P. Cina1, K. R. Sherwood2, S. Dobrer2, J. Wong3, F. Fenninger2, M. Kadatz4, P. Keown4, J. Lan4

  • Impact of Belatacept and Tacrolimus on Cmv Viral Load Control and Relapse in Moderate and High-risk Cmv Serostatus Kidney Transplant Recipients

    W. Magua1, A. C. Johnson1, G. M. Karadkhele1, I. R. Badell1, P. Vasanth1, M. G. Lyon III2, A. K. Mehta2, K. A. Easley3, J. Rickert4, C. P. Larsen1

  • Impact of CHA2DS2-VASc Score on Postoperative Mortality Following Kidney Transplant

    J. Klein1, M. Rangel1, Z. Spigel2, E. Hollinger1, D. Olaitan1, M. Hertl1, E. Chan1

  • Impact of Community- Targeted Educational Campaign on Living Donor Transplants

    S. Ganesh, A. Humar

  • Impact of COVID-19 Crisis on Disparities in Living Kidney Donation in the US

    J. Wainright, S. Booker, J. Foutz, A. Henderson, R. Goff, L. Cartwright, D. Klassen

  • Impact of Covid-19 in Transplant Care: Attitudes, Feeling and Behaviors of Liver, and Kidney Pre and Post Transplant Patients

    J. Ramos-Ayes

  • Impact of Covid-19 Infection on Tacrolimus Levels in Solid Organ Transplant Recipients

    K. Heagler, K. Tejani, S. Sanchez

  • Impact of COVID-19 on Solid Organ Transplantation

    E. Sampson1, S. Hall2, K. Robichaux3, A. Kumar2, N. Kemmer4, J. Buggs5

  • Impact of Cypa5 Status on the Clinical and Financial Outcomes of Kidney Transplant

    J. Obayemi1, B. Keating2, K. Lentine3, M. Schnitzler3, H. Xiao3, V. Dharnidharka4, D. Axelrod5

  • Impact of Cytomegalovirus Prophylaxis on Herpes Simplex and Varicella Zoster Virus Infections in Kidney Transplant Recipients

    K. Ridgely1, B. Crowther2, P. Klem2, K. Schoeppler1, K. Schwarz1, A. Nadrash2, V. Lewis1, E. Benamu3

  • Impact of Deceased Donor Mode of Death and Kidney Donor Profile Index on Baseline Donor Derived Cell Free DNA in Kidney Transplant Recipients

    B. Chopra, A. Grazier, K. K. Sureshkumar

  • Impact of Donated Kidney Volume and Recipient Body Surface Area Incompatibility on the Allograft Outcomes with Pre-transplant Diabetes Mellitus

    Y. Park1, H. Lee2, E. Ko2, C. Yang2, B. Chung2

  • Impact of Donation After Circulatory Death Donor Allografts on Outcomes Following Liver Transplantation for Cholangiocarcinoma

    S. Kumar1, S. Lin2, J. D. Schold2

  • Impact of Donor and Recipient Age Difference: Outcomes within the First Year of Orthotopic Heart Transplant

    M. Mascetti, M. Manson, Z. Truman

  • Impact of Donor Kidney Biopsy on Kidney Yield and Post-Transplant Outcomes

    C. Wang1, J. Wetmore1, A. Wey2, N. Salkowski2, J. Snyder2, A. Israni1

  • Impact of Early versus Late Ureteric Stent Removal and Antibiotic Prophylaxis on Urinary Tract Infection Incidence in Kidney Transplant Adult Recipients

    K. Althiab1, B. Alqahtani2, R. Alotaibi3, R. Alhussein3, R. Almuhiteb2, L. Alnajjar2, M. Alqahtani2, K. Bin Saad4, W. Ohali4, A. Tamimi4, M. N. Almarastani4, S. Kashkoush4, G. Aboalsameh4, M. Shaheen4, M. Tawhari4, A. Altheaby4, Z. Arabi5

  • Impact of Electronic Donor Referral Technology on Deceased Donor Referrals

    B. Boyarsky1, J. R. DiRito2, K. Vanterpool1, J. Piano3, W. Liu3, J. Hewlett4, C. Trahan4, D. Segev1, M. Levan1, A. Massie1, P. Niles4

  • Impact of Elevated Initial Donor Creatinine on Outcomes After Transplanting Kidney from Deceased Donor with Severe AKI

    L. Kodali, K. Reddy, P. Budhiraja, S. Nair, G. Mour, J. Huskey, C. Jadloweic, H. Khamash, H. Chakkera, R. Heilman

  • Impact of Extended Living Donor Criteria on Donor Safety in Living Donor Liver Transplantation

    J. KIM

  • Impact of Graft Quality on Patient Survival in Sick Patients

    G. Handing1, S. Keeling1, C. Christmann1, N. Galvan2, C. O’Mahony2, J. Goss2, R. Cotton2, A. Rana2

  • Impact of High-Risk EBV Discordance Status on Survival Outcomes in Kidney Transplant Recipients: A Multivariable Analysis

    A. Dinesh1, S. Jackson2, T. L. Pruett1, S. Riad3

  • Impact of Induction Immunosuppression Selection on Clinical Outcomes in Kidney Transplant Recipients During the COVID-19 Pandemic in New York City

    K. Khalil, S. Jonchhe, J. Stern, T. C. Lewis, N. Alnazari, B. Lonze, Z. Stewart Lewis, N. Ali

  • Impact of Insulin Therapy in Pancreas Transplantation Donors on Graft Outcomes: An Analysis of the Optn/unos Database

    E. Montagud-Marrahi1, F. Ausania2, Y. Fundora2, A. Amor3, E. Esmatjes3, J. Ferrer2, I. Revuelta1, D. Cucchiari1, J. Rovira4, M. Musquera5, C. Fondevila2, F. Diekmann1, P. Ventura-Aguiar1

  • Impact of Liver Acuity Circles on Timing of Donor Procurements

    R. Radhakrishnan, D. Goldberg

  • Impact of Lung Allocation Score Cohort Update

    M. Skeans1, A. Wey1, E. Lease2, C. Lehr3, M. Valapour3

  • Impact of Machine Perfusion of the Heart on Abdominal Organ Procurement from Donation After Cardiac Death Donors

    C. Feizpour, C. Hwang, A. Shubin, J. Shah, L. DeGregoria, S. Hanish, P. Vagefi, M. MacConmara

  • Impact of New Onset Diabetes After Transplantation on Heart Transplant Recipients

    W. Kang1, W. Keattiyoat2, M. Kim1, C. Bhardwaj2

  • Impact of Non-active Hepatitis B on Patient Survival After Renal Transplantation

    A. Paschereit1, K. Budde2, M. Duerr2, M. G. Naik2

  • Impact of Once-Daily Extended-Release Tacrolimus Intrapatient Variability in Stable Adolescent and Young Adult Renal Transplant Recipients – 3 Year Results

    M. M. Chandran1, E. Blanchette1, J. Goebel2, M. Bock1

  • Impact of Pediatric Living Donor Liver Transplant Center Volume on Waiting List and Post-Transplant Outcomes

    D. Yoeli, R. A. Choudhury, H. B. Moore, T. L. Nydam, M. E. Wachs, E. A. Pomfret, M. A. Adams

  • Impact of Positive Donor Cultures on Postoperative Lung Transplantation Infectious Outcomes

    A. Curtis, C. Pham, B. P. Pierce

  • Impact of Pre- and Post-transplant Outcomes on Patient-reported Outcomes in a Prospective Multicenter Trial in Kidney Transplantation

    J. M. Rohan1, J. P. Leone2, E. Woodle3, D. Kaufman4, A. R. Shields3, A. Wiseman5, A. J. Matas6, P. West-Thielke7, E. King3, R. R. Alloway3

  • Impact of Pre-Screening on OPTN Kidney Paired Donation Pilot Program Transplant and Refusal Rates

    S. E. Booker1, R. Leishman1, J. Musick1, M. Oley1, T. Sandholm2, J. Dickerson3, M. Pavlakis4, V. Casingal5

  • Impact of Rejection in Pediatric and Young Adult Kidney Transplant Recipients on the Use of Mental Health Resources

    E. Ruzicka1, E. Lyons2, C. Naclerio2, A. Sikora2, K. McKinnon2, E. Blanchette2, M. Chandran2, M. Bock2, E. Christofferson2

  • Impact of Rituximab Induction Therapy on Donor-specific Anti-HLA Antibodies in Abo-compatible Kidney Transplant Recipients

    T. Yagisawa1, T. Kanzawa1, K. Unagami2, M. Furusawa1, M. Inui1, H. Ishida2, K. Tanabe1

  • Impact of SARS-CoV 2 Infection on Graft Function in Kidney Transplant Recipients: An Academic Single Center Experience

    S. Nahi, A. Shetty, S. Tanna, J. Leventhal

  • Impact of Sars-cov-2 Infection in Waiting List for Liver Transplantation: A Cohort Study on Clinical Outcomes

    A. Sessa, A. Mazzola, B. Granger, D. Wakselman, M. Atif, V. Martinez, M. Mallet Maxime, D. Thabut, O. Scatton, F. Conti

  • Impact of Social Support, Social Circumstances and Distance from Transplant Center on Post Liver Transplant Outcomes: An Analysis from a Predominantly Rural U.S. Cohort

    R. Kaur1, C. Lavender1, E. Askew1, S. Jafri2, R. Thandassery1, M. Deneke1

  • Impact of Statin Intensity on the Incidence of Vascular Events and Graft Survival in Heart Transplant Recipients

    E. Kim1, I. Booth2, R. Madathil3, B. Ravichandran1, M. Demehin2, M. Plazak2

  • Impact of the Covid-19 Pandemic on Transplant Pharmacist Workforce

    J. Lyons1, K. Khalil2, J. J. Teuteberg3, E. J. Henricksen4

  • Impact of the Kidney Allocation System on Kidney Transplant Outcomes in Patients with Long Dialysis Treatment (> 10 Years)

    M. Kadatz, S. Vaishnav, S. Brar, D. Chang, J. Lan, J. Gill

  • Impact of the Transplant Clinical Pharmacist in an Outpatient Transplant Clinic

    O. Roe1, S. Gattis1, R. Parsons2, D. Lo2, S. Todd1

  • Impact of Transplant Center Volume on Utilization of and Outcomes Following Donation After Circulatory Death Liver Transplantation in the United States

    S. Kumar1, S. Lin2, J. D. Schold2

  • Impact of Traveling for Transplant on Access to and Outcomes from Kidney and Liver Transplantation

    K. Ross-Driscoll1, R. Lynch1, D. Axelrod2, R. Patzer1

  • Impact of Treatment of Subclinical Rejection at 2 Weeks After Kidney Transplantation, Compared by 1 Year Histologic Outcomes

    O. Lee1, K. Lee1, J. Park1, J. Lee2, G. Kwon3, K. Kim4

  • Impact of Valganciclovir Prophylaxis Dosing in High Risk Cytomegalovirus Kidney and Pancreas Transplant Recipients with Delayed Graft Function

    A. Gharabagi1, J. Geyston1, A. Agarwal2, S. Rao3, A. Doyle3, J. Dann1

  • Impaired Antibody Responses to Spike Protein Antigens of Sars-cov-2 in Solid Organ Transplant (sot) Recipients

    C. Ashokkumar1, S. Nadig2, V. Rohan2, A. Kroemer3, H. Dhani3, S. Rao4, R. Sindhi5

  • Implementation of a High-risk Medication Report for Waitlisted Liver Transplant Candidates

    M. M. Eiting1, H. Yeh2, M. Cote1, S. Shao1, A. B. Scherrer2, L. Dageforde2, N. Elias2, C. Rogers Marks1

  • Implementation of an Alcohol Screening Program Identifies Active Pre-transplant Drinking and Allows Engagement in Chemical Dependency Treatment

    N. Lim1, T. Leventhal1, M. Thomson1, M. Hassan1, J. Thompson1, S. Chinnakotla2, V. Kirchner2, T. Pruett2, R. Kandaswamy2, V. Humphreville2, A. Adams2, J. Lake1

  • Implementation of the Kidney Team at Home Intervention: Evaluating Generalizability, Implementation Process, and Effects

    S. Redeker1, S. Ismail1, R. Timman1, J. van Busschbach1, C. Boonstra2, H. F. Brulez3, D. A. Hollander4, L. Hilbrands5, F. J. Bemelman6, S. P. Berger7, J. van der Wetering8, R. A. van den Dorpel9, M. A. Jansen-Dekker10, W. Weimar8, E. K. Massey8

  • Implications of Trends in Child to Parent Kidney Donation in Whites and African Americans

    N. Jean, S. Krishnamoorthy, Y. Kyeso, P. Cunningham, N. Murthy, R. McGill, M. Josephson

  • Improved Outcomes Over Time of Extended Criteria Donor Grafts for Acute-on-chronic Liver Failure

    T. Kitajima, T. Ivanics, D. Moonka, T. Shamaa, A. Mohamed, K. Delvecchio, K. Collins, M. Rizzari, A. Yoshida, M. Abouljoud, S. Nagai

  • Improved Patient Survival in DCD Liver Transplantation

    O. Bushara1, J. Alhalel1, H. Azad1, T. Cerri2, S. Zafer2, J. C. Caicedo1

  • Improving Allograft Survival by Informing Donor Selection in Kidney Transplant Recipients Under 5 Years Old

    F. Manca Barayre, L. Greenbaum, R. Garro, P. Winterberg, R. Patzer, J. Hogan

  • Improving Eligibility of Renal Transplants in the Elderly

    L. B. Moraitis, J. Rogers, A. Farney, A. Reeves-Daniel, G. Orlando, W. Doares, S. Kaczmorski, A. Mena-Gutierrez, C. Jay, R. Stratta

  • Improving Liver Transplantation Outcomes for Hepatitis C Associated Hepatocellular Carcinoma in Direct-Acting Antiviral Therapy Era

    K. Okumura, H. Sogawa, G. Veillette, D. John, T. Diflo, R. Bodin, D. C. Wolf, S. Nishida

  • Improving Policy-constrained Kidney Exchange via Pre-screening

    D. C. McElfresh1, M. Curry2, S. Booker3, M. Stuart3, D. Stewart3, R. Leishman3, T. Sandholm4, J. Dickerson2

  • Improving Well-being for Heart Transplant Recipients: Implementation of a Patient Navigator Program

    K. Ramonas, K. Ramonas

  • In Search of a Better Outcome: Opting Into the Live Donor Paired Kidney Exchange Program

    A. J. Vinson1, B. Kiberd2, K. J. Tennankore1

  • In Vitro Generated Regulatory B Cells Induce Cd4+Cd25+Foxp3+Tregs from Cd4+Cd25–T Cells via TGF-β

    G. Huai1, K. Lee2, K. Deng2, Q. Fu1, C. G. Rickert2, S. Deng1, C. LeGuern2, J. F. Markmann2

  • Incidence and Risk Factors for Nonmelanoma Skin Cancer in Lung Transplant Recipients

    G. Holdren1, E. Lushin1, M. Duncan2, C. Hage2

  • Incidence of Oral Candidiasis in Renal and/or Pancreas Transplant Recipients When Administering Prophylaxis versus No Prophylaxis

    L. Von Stein1, S. Patel1, L. Wardlow2

  • Incidence of Pancreatic Exocrine Insufficiency in Patients Undergoing Liver Transplantation

    J. Klein1, M. Rangel1, I. Ifearulundu1, Y. Gely1, Z. Spigel2, S. Janardhan3, M. Hertl1, E. Chan1

  • Incidentally Detected Malignancies in Lung Explants: Single Center Case Series

    D. Razia, A. Arjuna, L. Schaheen, J. Huang, M. Smith, R. Bremner, R. Walia

  • Incorporation of Donor Liver Macrovesicular Steatosis Into Srtr Risk Adjustment Models for Deceased Donor Yield and Post-Transplant Outcome

    A. Kwong1, C. Wang2, A. Wey3, N. Salkowski3, J. Snyder4, J. Wetmore2, A. Israni2, J. Lake4, P. Stock5, W. Kim1

  • Increased Deceased Organ Donation Rates Among Racial and Ethnic Minorities: Not Exactly. A UNOS/NHSBT UK Donor Data Analysis Over the Last Five Years

    H. Sharma1, A. Pradeep2, A. Ditchfield3, M. Abraham4, P. Lominchar5, S. Mehra1, A. Skaro4

  • Increased T Cell Cross-dressing in Accepted Kidney Allografts

    Q. Yuan1, S. Hong2, E. Szuter2, I. Rosales2, Y. Zhao2, B. Gonzalez-Nolasco2, G. Benichou2, P. Russell2, J. Madsen2, R. Colvin2, A. Alessandrini2

  • Increasing Survival on the Kidney Transplant Waiting List: A Thirty-Three Year Analysis

    E. L. Godfrey1, P. T. Kambhampati1, J. A. Goss2, A. Rana2

  • Indocyanine Green Fluorescence Imaging Allows Quantification of Ischemic Injury During Porcine Normothermic Ex Situ Perfusion

    T. Goto, Y. Noguchi, S. Ganesh, L. Mazilescu, T. Reichman, N. Selzner, M. Selzner

  • Inducing Transient Mixed Chimerism without Chimeric Transition Syndrome for Tolerance Induction After Kidney Transplantation

    K. Lee, J. Park

  • Induction Immunosuppression Efficacy in Pancreas and Kidney Transplantation in the SARS-CoV-2 Era

    H. Sarumi, K. Vassar, S. Jackson, T. Pruett, R. Kandaswamy

  • Induction in Pancreas Transplantation: T-Cell Depletion vs. Il-2 Receptor Blockade

    F. Aziz, S. Parajuli, D. Kaufman, J. Odorico, D. Mandelbrot

  • Infection Rates in Heart Transplant Recipients With Combined Tacrolimus and Sirolimus at High versus Low Concentrations

    S. Goyal, J. Lyons, J. Negrelli, M. Liebo, A. Heroux

  • Infectious Complications After Belatacept Conversion in Kidney Transplant

    J. E. Marvin1, D. Amenyedor1, M. M. Azar2, K. Belfield1, V. Do1, R. Formica3, E. Cohen1

  • Infectious Complications and Malignancy After Kidney Transplantation in the Elderly Population

    L. Liriano-Ward, M. Parides, Y. Al Azzi, C. Pynadath, M. Ajaimy, P. Loarte, J. Graham, S. Greenstein, M. Le, H. Yaffe, M. Kinkhabwala, J. Rocca, E. Akalin

  • Inflammation in Scarred Cortex (i-IFTA) is Significantly Associated with T Cell-mediated Rejection (TCMR), but Not Antibody-mediated Rejection (ABMR), in Renal Allograft Biopsies (Bx)

    H. Zhang

  • Influence of Controlled Donation After Circulatory Death (cdcd) on Waiting List Mortalityfor Liver Transplantation in the Last 10 Years: The Spanish Experience

    F. Alconchel, M. Royo-Villanova, J. Moya, L. Martínez-Alarcón, J. Zambudio, P. Cascales-Campos, T. Nicolás, R. Robles, F. Sánchez-Bueno, J. Pons, J. Rodríguez, A. Ríos, J. Fernández, P. Ramírez

  • Influence of Frailty on Psychometric Factors and Health-related Quality of Life in Patients on the Waitlist for Liver Transplantation

    C. G. Klein, J. Latuske, E. Malamutmann, A. Paul, A. Oezcelik

  • Influence of HLA Compatibility on Bk Virus Associated Nephropathy Among Japanese Living Donor Kidney Transplant Recipients

    N. Fujiyama1, M. Saito2, R. Yamamoto2, R. Sagehashi2, T. Saito2, S. Kashima2, K. Numakura2, S. Narita2, T. Habuchi2, S. Satoh1

  • Influence of Immunosuppressant Management on Mortality in Kidney Transplant Recipients Hospitalized with COVID-19

    Y. Fenig, A. Santeusanio, M. Menon, C. Liu, M. Rana, R. Shapiro

  • Influence of Immunosuppressive Drug Trough Levels on Nk Cells in Liver Transplantation

    R. Qin1, J. Qin2, C. Sun3, B. Nashan1

  • Influence of Induction Therapy and Antiretroviral Regimen on Outcomes in HIV Positive Renal Transplant Recipients

    C. Rogers Marks1, C. Durand2, J. Hand3, M. Abidi4, M. Malinis5, B. Barnaba2, H. Patel6, C. D. Alonso6

  • Influence of Vitamin D Status on the Prognosis of Covid 19 in Patients with Kidney Transplant

    J. Ugalde-Altamirano, I. Revuelta, A. Carrillo, M. Xipell, F. Cofan, N. Esforzado, E. Montagud, G. Piñeiro, A. Molina, P. Ventura, D. Cucchiari, F. Oppenheimer, F. Diekmann, J. Campistol, B. Bayes, J. Torregrosa

  • Information-Seeking Behavior During Covid-19: Opportunities for Communication and Care Transition Improvements

    S. H. Advani1, S. M. Advani2, Y. A. Iraheta3, A. Murillo4, H. A. Gritsch3, A. D. Waterman3

  • Inhibition of Apoptosis During Ex Situ Liver Normothermic Machine Perfusion Decreases Reperfusion Injury and Improves Viability

    S. Raigani1, S. Baptista1, A. Ohman2, J. Santiago2, I. Rosales1, M. Heaney2, J. Boylan2, T. Coe1, K. Uygun1, J. Sanders2, H. Yeh1

  • Inhibition of Fatty Acid Beta-Oxidation Prolongs Heart Allograft Survival

    B. W. Wong, Y. Zhu, H. Dun, L. Ye

  • Initial Experience with Growth Hormone Receptor Knockout in Pig-to-Baboon Kidney Transplantation: Effect on Ureteric Viability and Kidney Growth

    C. Hansen-Estruch1, H. Iwase1, A. Jagdale1, T. Yamamoto1, M. H. Bikhet1, J. Foote2, H. Hara1, D. Anderson1, P. Porrett1, D. Eckhoff1, D. Ayares3, W. Eyestone3, J. Locke1, D. K. Cooper1

  • Initial Experience with Single-port Robotic-assisted Kidney Transplantation

    M. Eltemamy, A. Aminsharifi, Y. Lin, Z. Schwen, M. Abou Zeinab, V. Krishnamurthi, D. Goldfarb, A. Wee, J. Kaouk

  • Initial Experience with TrugrafTm Gene Expression Profile and TracTm Dd-cfdna Testing in Kidney Transplant Recipients Suggests Synergy and Enhanced Management within the First Year Post-transplant and Beyond

    V. Paramasivam, B. Greco, M. Germain

  • Initial Experiment of Self-expanding Metal Ureteral Stent in Recurrent Ureteral Stenosis After Kidney Transplantation

    Q. Zhong, T. Song, J. Zeng, Y. Fan, X. Wei, T. Lin

  • Initial Kidney Transplant Evaluations with Telehealth: Is it a Pandemic Only Practice?

    A. Govil1, E. Tims2, C. Siemer2, J. Harris2, C. King2, S. Shah1, C. Thakar1

  • Insulin Secretion and Insulin Resistance Trajectories Over 1 Year After Kidney Transplantation: A Multicenter Prospective Cohort Study

    B. Jun Bae, C. Oh

  • Integrative Analyses of Circulating Small Rnas and Paired Kidney Graft Transcriptome in Transplant Glomerulopathy

    C. Kuscu1, K. Manjari2, M. Akram3, C. Kuscu4, A. Wolen,4, A. Bajwa4, J. Eason4, D. G. Maluf5, V. Mas6, E. Akalin7

  • Intensive Blood Pressure Control Preserves Kidney Allograft Function

    K. A. Agarwal1, U. K. Agarwal2, G. S. Silva3, K. J. Pollick3, M. Pavlakis1

  • Intensive Monitoring and Early Treatment for Urinary Infection in Renal Transplant Recipients Reduces Readmission and Sepsis

    A. Patel, S. Desai, B. R. Schleich, M. Wynd, T. Carrea, Y. Yushkov, S. Geatrakas, N. White, R. Luongo, R. Sosnicki, V. Wadhera, D. Serur, M. J. Goldstein

  • Intensivist-Performed Transesophageal Echocardiography as a Screen for Organ Donation: A Four-Year, Single-Center Experience

    K. M. Madden1, T. C. Wray2, K. Rainbird1, I. Tawil2, T. Dettmer2, K. Azevedo2, R. Venkataramani3, J. Marinaro2

  • Intermediate Outcomes Following Early Inflammatory Changes on Surveillance Biopsies

    I. Melgarejo1, V. Viswanathan2, A. Sharma1, P. Sood1, C. Puttarajappa1, N. Shah1, M. Molinari1, A. Tevar1, C. Wu1, S. Hariharan1, R. Mehta1

  • Interruption of Notch Signaling via Blockade of Delta-Like Ligand 4 Prevents Co-Stimulation Blockade Resistant Allograft Rejection

    A. J. Matar, B. P. Lovasik, Y. Dong, D. A. Faber, J. Habib, C. Breeden, J. Regenold, A. Ghosh, A. Stephenson, W. H. Kitchens, A. B. Adams

  • Intersecting Disparities in Health Literacy Among Renal Patients Experiencing Transplant Barriers

    C. W. Nonterah, K. Workman, S. Shah

  • Intestinal Insufficiency May Affect Outcomes After Pediatric Liver Transplantation

    A. K. Batra, M. Desai, J. Yang, K. Cummins, H. Oden-Brunson, H. Ling, S. Beer, J. Goss, N. Galvan

  • Intrahepatic Spatial Location of HCC Recurrence Following Loco-regional Therapy for Solitary Tumors Predicts a Higher Oncologic Risk & Increased Recurrence Post-transplant

    A. Mathur, E. Baughan, S. Haider, A. Griesemer, T. Kato, J. Emond

  • Intraoperative Fluid Management and Kidney Transplantation Outcomes: A Retrospective Review

    M. W. Harbell1, M. B. Kraus1, S. A. Buckner Petty2, J. W. Harbell3

  • Intrarenal B-cell Activating Factor (BAFF) Levels are Increased in Transplant Glomerulopathy

    S. Panzer, K. Swanson, G. Pandya, L. Hidalgo, S. Reese

  • Intravenous Immunoglobulin in Heart Transplant Recipients with Hypogammaglobulinemia and Infection

    J. Hoang, D. Nguyen, E. Graviss, M. Moaddab, A. Guha, J. Krisl

  • Intravenous Immunoglobulin Protects Liver Allograft from Ischemia Reperfusion Injury in Human Liver Transplantation

    S. Yokota, J. C. Alonso-Escalante, R. P. Tindall, K. R. Tabar, L. Machado, T. Uemura, N. L. Thai

  • Invariant Nkt Cells Promote Expansion of Novel Cxcr3+Ccr4+Cd8+ T Cells in the Liver Following Allogeneic Hepatocyte Transplant

    J. Zimmerer1, B. Ringwald2, S. Chaudhari1, J. Han1, C. M. Peterson1, R. T. Warren1, M. Hart1, M. Abdel-Rasoul3, G. Bumgardner1

  • Investigating Physician Outlook Regarding Living Donation Prior to Planned Withdrawal of Care

    S. Rath1, L. Washburn2, S. Creden1, M. Goss3, A. Rana1, J. Goss1, N. T. Galvan1

  • Investigating the HLA Alloimmune Background of the Histological Changes Suggestive of Antibody-mediated Injury in the Absence of Donor-specific Anti-HLA Antibodies

    A. Senev, M. Naesens

  • Is Equitable Access to Transplantation Possible in the Era of HLA Epitope Compatibility?

    S. Parto1, J. Lamsatfi2, B. Liu2, A. Bourdiec2, B. Foster2, K. Oualkacha2, F. Claas3, P. Keown4, R. Sapir-Pichhadze5

  • Is Low Systemic Fibrinolytic Activity During the Anhepatic Phase Liver Transplant Surgery Associate with the Dreaded Post-Operative Complication of Hepatic Artery Thrombosis?

    H. B. Moore1, Y. Bababekov1, J. Pomposelli1, T. Ferrell1, F. Azam1, M. Adams2, D. Yoeli1, R. Choudhury1, M. Wachs2, E. Pomfret1, T. Nydam1

  • Is Subclinical Allograft Rejection by 2019 Banff Criteria Associated with Worse Kidney Allograft Outcomes? Comparison Between 2007 and 2019 Banff Criteria

    M. T. Victor1, S. Park2, K. Guo1, L. Zhao1, J. Friedewald3

  • Is There a Role for Donor-Specific Antibody Testing in Simultaneous Liver-Kidney Transplantation? A Single Center Analysis of Outcomes

    A. Das, A. Barbetta, D. Remulla, C. Goldbeck, T. Maw, J. Kim

  • Is There a Role for Pre-Operative Angiographic Kidney Embolization Prior to Allograft Nephrectomy?

    M. Jacobs1, R. Stratta1, D. Harriman2, A. Farney1, J. Rogers1, G. Orlando1, A. Reeves-Daniel1, C. Jay1

  • Islet Allotransplantation Into Pre-vascularized Sernova Cell PouchTM – Preliminary Results from the University of Chicago

    P. J. Bachul1, P. E. Borek1, G. S. Generette1, A. Perez-Gutierrez1, K. Jayant1, K. Golab1, L. Basto1, L. Perea1, M. Tibudan1, C. Thomas2, L. Philipson2, J. Fung1, P. Witkowski1

  • Islet Isograft Transplantation Improves Insulin Sensitivity in a Murine Model of Type 2 Diabetes

    S. Lim, M. Choi, M. Kim, Y. Wee, H. Kwon, C. Jung, Y. Kim, D. Han, S. Shin

Jump to:  View All • a b c d e f g h [i] j k l m n o p q r s t u v w x y z

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences